NCT05222451

Brief Summary

This study will test the effect of diet on asthma in individuals with obesity.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for not_applicable asthma

Timeline
Completed

Started Jun 2022

Typical duration for not_applicable asthma

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 5, 2022

Completed
29 days until next milestone

First Posted

Study publicly available on registry

February 3, 2022

Completed
5 months until next milestone

Study Start

First participant enrolled

June 27, 2022

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 18, 2024

Completed
13 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

February 4, 2025

Status Verified

January 1, 2025

Enrollment Period

2.5 years

First QC Date

January 5, 2022

Last Update Submit

February 3, 2025

Conditions

Keywords

ketonedietmetabolism

Outcome Measures

Primary Outcomes (4)

  • Asthma Control

    Asthma Control Questionnaire score (Juniper; 1 week recall period) Score range: 0-6. Minimally important difference = 0.5.

    Baseline

  • Asthma Control

    Asthma Control Questionnaire score (Juniper; 1 week recall period) Score range: 0-6. Minimally important difference = 0.5.

    After 7 days on Diet#1

  • Asthma Control

    Asthma Control Questionnaire score (Juniper; 1 week recall period) Score range: 0-6. Minimally important difference = 0.5.

    After 7 days on Diet#2

  • Asthma Control

    Asthma Control Questionnaire score (Juniper; 1 week recall period) Score range: 0-6. Minimally important difference = 0.5.

    After 7 days on Diet#3

Secondary Outcomes (12)

  • Lung Function

    Baseline

  • Lung Function

    After 7 days on Diet#1

  • Lung Function

    After 7 days on Diet#2

  • Lung Function

    After 7 days on Diet#3

  • FENO

    Baseline

  • +7 more secondary outcomes

Study Arms (3)

Dietary Guidelines for Americans

EXPERIMENTAL

7 days of a diet consistent with the Dietary Guidelines for Americans (DGA).

Other: DGA Diet

Medium Chain Triglyceride Supplemented DGA

EXPERIMENTAL

7 days of a diet consistent with the Dietary Guidelines for Americans supplemented with medium chain triglycerides (MCT).

Other: MCT Diet

Ketogenic Diet

EXPERIMENTAL

7 days of a ketogenic diet (KETO).

Other: KETO Diet

Interventions

A fully provisioned isocaloric, isonitrogenous study diet following the Dietary Guidelines for Americans (DGA) Including: * A variety of vegetables and fruits * Grains, at least half of which are whole grains * Fat-free or low-fat dairy * A variety of protein foods, including seafood, lean meats and poultry, eggs, legumes, nuts, and seeds * This healthy eating pattern also limits saturated fats and trans fats, added sugars, and sodium.

Dietary Guidelines for Americans

A fully provisioned isocaloric, isonitrogenous study diet following the Dietary Guidelines for Americans supplemented with medium chain triglycerides (MCT).

Medium Chain Triglyceride Supplemented DGA

A fully provisioned isocaloric, isonitrogenous ketogenic study diet.

Ketogenic Diet

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age: 18-65 years
  • BMI: 30-45 kg/m2
  • asthma diagnosed by medical specialist (confirmed in medical history)
  • partly controlled or uncontrolled asthma by Asthma Control Test score ≤22
  • owns a device compatible with ZEPHYRx platform
  • stable asthma medication use (no change in the past 2 months).

You may not qualify if:

  • Diabetes or using diabetes medications that may lower blood glucose levels
  • point of care fasting blood glucose ≥126 mg/dl or triglycerides ≥400 mg/dl
  • current smoking or smoking history of greater than 10 pack-years
  • other significant respiratory or cardiac disease or the presence of clinically important comorbidities, e.g., COPD, renal failure, liver disease; uncontrolled hypertension defined as systolic blood pressure ≥160 mm/Hg, or diastolic blood pressure ≥100 mm/Hg
  • pregnant or nursing women
  • food preferences or allergies inconsistent with study diet capabilities
  • noncompliance with lead-in period requirements.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Pennington Biomedical Research Center

Baton Rouge, Louisiana, 70808, United States

Location

MeSH Terms

Conditions

AsthmaObesityKetosis

Interventions

Diet, Ketogenic

Condition Hierarchy (Ancestors)

Bronchial DiseasesRespiratory Tract DiseasesLung Diseases, ObstructiveLung DiseasesRespiratory HypersensitivityHypersensitivity, ImmediateHypersensitivityImmune System DiseasesOverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsAcidosisAcid-Base ImbalanceMetabolic Diseases

Intervention Hierarchy (Ancestors)

Diet, Carbohydrate-RestrictedDiet TherapyNutrition TherapyTherapeuticsDietNutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological Phenomena

Study Officials

  • Jacob T Mey, PhD, RD

    Pennington Biomedical Research Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Participants will not be made aware of the diet allocation. However, due inherent differences in macronutrient content of the diets, participants may perceive differences in the quantity of various food groups or in the taste, texture or smell of foods present in the diet. To address this, diets will be designed to minimize noticeable differences for the participant. The investigator and outcomes assessor will remain fully masked to diet provision.
Purpose
OTHER
Intervention Model
FACTORIAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

January 5, 2022

First Posted

February 3, 2022

Study Start

June 27, 2022

Primary Completion

December 18, 2024

Study Completion

December 31, 2024

Last Updated

February 4, 2025

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will not share

Study data will be provided upon request and approval by study PI.

Locations